Marksans Pharma Announces 34th AGM on August 27, 2026

Marksans Pharma Ltd has issued a notice for its 34th Annual General Meeting (AGM) scheduled for August 27, 2026. The meeting will be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM). Shareholders will have the opportunity to participate in e-voting from August 24 to August 26, 2026. Key agenda items include the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, the declaration of a final dividend of ₹0.90 per equity share, the re-appointment of a director retiring by rotation, and the special business of approving the re-appointment and remuneration of Mrs. Sandra Saldanha as a Whole-time Director for three years.